CYCN vs KMI · $8.6M cap vs P/E 24, rev $9.30B
Cyclerion Therapeutics Inc (CYCN) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
CYCN currently screens at market cap $8.6M. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the CYCN and KMI stock pages for the full models.
Not investment advice.